Johnson & Johnson (NYSE: JNJ) announced today that it would name one of its two companies, a consumer health company ahead of its spin-off as Kenvue. The company stated that "Kenvue (pronounced ken·view), is inspired by two powerful ideas: “ken” – meaning knowledge, an English word primarily used in Scotland, and “vue,” referencing sight." Is J&J a Good Stock to Buy? Wall Street analysts are cautiously optimistic about the stock with a Moderate Buy consensus rating based on six Buys and four Holds. The average price forecast for JNJ stock is $188.33 implying an upside potential of 13%.
https://www.tipranks.com/news/johnson-johnson-nyse-jnj-to-name-new-company-post-spin-off-as-kenvue?utm_source=advfn.com&utm_medium=referral
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Johnson and Johnson Charts.